- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Growth Potential Companies
U.S. Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Apr 28, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
169 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SRPT | US$128.77 | 10.1% | 2.9% | US$12.2b | US$164.54 | PS9.8x | E42.6% | n/a | ||
CKPT | US$1.43 | -1.4% | -55.6% | US$51.0m | US$17.25 | PS495.5x | E88.1% | n/a | ||
EVOK | US$0.46 | 0.7% | -76.3% | US$3.9m | US$7.00 | PE-0.5x | E101.6% | n/a | ||
CAPR | US$5.41 | 9.5% | 38.4% | US$170.4m | US$21.00 | PS6.8x | E59.4% | n/a | ||
BFRI | US$1.59 | 10.0% | -86.1% | US$8.1m | US$16.00 | PB1.7x | E65.8% | n/a | ||
PGEN | US$1.41 | 2.2% | 19.5% | US$351.0m | US$9.00 | PS56.4x | E55.5% | n/a | ||
MDWD | US$18.24 | 15.7% | 61.4% | US$168.8m | US$28.50 | PS9x | E56.3% | n/a | ||
TBPH | US$9.12 | -3.6% | -17.2% | US$442.9m | US$15.40 | PS7.7x | E61.4% | n/a | ||
CRMD | US$5.31 | 0.6% | 3.7% | US$291.9m | US$13.00 | PB4.2x | E59.6% | n/a | ||
SPPI | US$1.03 | 5.3% | 17.0% | US$209.9m | US$1.26 | PS8.2x | E67.3% | n/a | ||
OCUP | US$1.61 | 6.6% | -73.3% | US$39.9m | US$19.50 | PS2.1x | E9.5% | n/a | ||
VRCA | US$6.87 | 1.2% | 5.9% | US$291.4m | US$13.60 | PS56.9x | E61.6% | n/a | ||
SBFM | US$0.95 | -34.0% | -98.4% | US$944.8k | US$15.00 | PB0.04x | E144.2% | n/a | ||
PRPH | US$4.71 | -3.9% | -39.3% | US$85.0m | US$21.00 | PS1.9x | E87.4% | 0% | ||
NBIX | US$135.99 | 1.7% | 30.7% | US$13.7b | US$153.63 | PE54.8x | E26.9% | n/a | ||
AMYT | US$14.70 | 0.7% | 86.5% | US$940.7m | US$20.75 | PS3.9x | E53.9% | n/a | ||
ACER | US$0.80 | -5.4% | -30.0% | US$19.7m | n/a | PE-0.5x | E66.2% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
ZYNE | US$1.30 | 4.0% | 96.1% | US$65.6m | US$1.26 | PB2.3x | E67.2% | n/a | ||
CTXR | US$0.66 | -9.5% | -55.7% | US$120.0m | US$4.00 | PB1.4x | E62.7% | n/a | ||
CASI | US$2.42 | -0.4% | -10.0% | US$31.4m | US$12.00 | PB1.3x | E57.6% | n/a | ||
LQDA | US$12.53 | -4.9% | 87.6% | US$952.6m | US$23.86 | PS54.5x | E59.6% | n/a | ||
OTLK | US$8.43 | 4.2% | -64.0% | US$196.4m | US$39.86 | PE-3.8x | E61.3% | n/a | ||
KRYS | US$156.88 | -0.2% | 82.0% | US$4.5b | US$188.50 | PE409.2x | E43.5% | n/a |